DOSE OF REALITY: NEW STUDY DEBUNKS BIG PHARMA CLAIMS THAT HIGH PRESCRIPTION DRUG PRICES ARE TIED TO R&D INVESTMENTS
JAMA Network Open Paper Finds “No Relationship” Between Drug Company’s… Read More
JAMA Network Open Paper Finds “No Relationship” Between Drug Company’s… Read More
Biogen Agrees to Settle Case Over Illegally Paying Doctors to Push Brand Name… Read More
Novartis Exec Calls Policy to Keep Price Hikes Below Inflation… Read More
Shining a Light on How Big Pharma is Rapidly Increasing Prices on Oncology… Read More
I-MAK Analysis Finds Anti-Competitive Practices That Extend Exclusivity Will… Read More
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices… Read More
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High… Read More
Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry… Read More